scispace - formally typeset
H

Hugo M. Horlings

Researcher at Netherlands Cancer Institute

Publications -  129
Citations -  18740

Hugo M. Horlings is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 46, co-authored 106 publications receiving 15805 citations. Previous affiliations of Hugo M. Horlings include BC Cancer Agency & University of Amsterdam.

Papers
More filters
Journal ArticleDOI

Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis

TL;DR: It is shown here that PTEN depletion abrogates BRAF(V600E)-induced senescence in human fibroblasts and melanocytes, and demonstrated that PI3K pathway activation serves as a rate-limiting event in this setting, acting at least in part by abrogating OIS.
Journal ArticleDOI

Genetic regulators of large-scale transcriptional signatures in cancer

TL;DR: This method shows that the wound response signature, a poor-prognosis expression pattern of 512 genes in breast cancer, is induced by coordinate amplifications of MYC and CSN5 (also known as JAB1 or COPS5).
Journal ArticleDOI

A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe

TL;DR: Supported by the recent evidence of the presence of B miyamotoi in Ixodes ricinus ticks across Europe, the relation in time of the patient’s symptoms with the tick bites, and his immunocompromised status, the patient was treated for a possible Lyme neuroborreliosis with once daily 2000 mg ceftriaxone intravenously for 2 weeks and fully recovered.
Journal ArticleDOI

An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential

TL;DR: In a study in patients with advanced BRAF+MEK inhibitor-resistant melanoma, vorinostat can selectively ablate drug-resistant tumor cells, providing clinical proof of concept for the novel therapy identified here.